Champignon Brands Appoints Dr Roger McIntyre As CEO

Champignon Brands (CSE: SHRM) this morning announced that it has named Dr Roger McIntyre as CEO of the firm effective immediately. Gareth Birdsall has relinquished his role to Dr McIntyre, and will continue to serve on the firms board of directors.

Dr Roger McIntyre is an expert in the field of psychedelics, and is known as the first person within Canada to successfully launch a treatment center for persons with mood disorders, referred to as the Canadian Rapid Treatment Centre of Excellence (CRTCE), which utilizes ketamine and psychedelic based treatments.

McIntyre currently holds a number of professional positions in relation to his field of study, which includes Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network. His other roles include executive directorships, chair positions, and professorships at numerous well respected global universities and foundations.

“My overarching aim as Chief Executive Officer is to establish Champignon as the apotheosis of integrated ketamine treatment delivery and the commercialization of our own IP psychedelic-based treatments. The clinical infrastructure, complementary asset base and human capital that Champignon has acquired leaves me very confident we will provide life changing treatments for persons with depression, all the while contemporaneously rewarding our investor base.”

Gareth Birdsall, the former CEO of Champignon Brands will remain with the firm in the role as a director. The company has also indicated that it is considering changing its name to better reflect its diverse business lines and operating subsidiaries.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Champignon Brands last traded at $1.00 on the CSE.


FULL DISCLOSURE: Champignon Brands is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Champignon Brands on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Champignon Brands Announces Contract Research Partner For Ketamine, Psilocybin IP Portfolio

Champignon Brands (CSE: SHRM) announced this morning that it is advancing its drug discovery program...

Monday, June 8, 2020, 10:03:37 AM

Champignon Brands To Resume Trading Today

Champignon Brands (CSE: SHRM) is expected to resume trading today after what was a nearly...

Friday, April 23, 2021, 08:22:55 AM

Champignon Brands Appoints Medipharm Labs CEO Pat McCutcheon to Board

This morning Champignon Brands Inc. (CSE: SHRM) announced the appointment of Pat McCutcheon to its...

Wednesday, May 6, 2020, 09:18:25 AM

Champignon Brands Latest Shroom Stock To IPO

Champignon Brands (CSE: SHRM) completed its initial public offering (IPO) late Friday night, with the...

Monday, March 2, 2020, 10:40:37 AM

Champignon Brands Announces Name Change, Spin Out Of CPG Division

Champignon Brands (CSE: SHRM) announced after the bell last night that it intends to change...

Saturday, June 13, 2020, 11:39:46 AM